The therapeutic potential of neuronal KCNQ channel modulators.
about
Therapeutic Strategies for Neuropathic Pain: Potential Application of Pharmacosynthetics and OptogeneticsVoltage-gated cation channel modulators for the treatment of strokePHARMACOLOGICAL TREATMENTS FOR TINNITUS: NEW AND OLDNovel, broad-spectrum anticonvulsants containing a sulfamide group: pharmacological properties of (S)-N-[(6-chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide (JNJ-26489112)Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound.Potassium channel subtypes as molecular targets for overactive bladder and other urological disorders.Retigabine.Dorsal-ventral gradient for neuronal plasticity in the embryonic spinal cordTranslational pain research: achievements and challengesThe contribution of Kv7 channels to pregnant mouse and human myometrial contractility.The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy.Coexpression and activation of TRPV1 suppress the activity of the KCNQ2/3 channel.Calmodulin regulates KCNQ2 function in epilepsy.Activation of peripheral KCNQ channels attenuates inflammatory pain.Combination therapy with flupirtine and opioid: studies in rat pain models.M channel enhancers and physiological M channel block.KCNQ/Kv7 channel regulation of hippocampal gamma-frequency firing in the absence of synaptic transmission.Kv7/KCNQ/M-channels in rat glutamatergic hippocampal axons and their role in regulation of excitability and transmitter release.Activation of KCNQ Channels Suppresses Spontaneous Activity in Dorsal Root Ganglion Neurons and Reduces Chronic Pain after Spinal Cord Injury.
P2860
Q26765373-858D6AF4-21AA-4A0B-8DF3-7E487112C50FQ28253754-6E2D6526-63BC-482B-B704-B5E26D897EA1Q30474822-C6A5F527-D902-430A-B78C-5AB905FF9538Q30577314-FF5323BF-46D6-40FB-893F-56DD1B85B8CFQ34985534-D89184BB-5FF5-413B-8337-153A473E558FQ35911129-5E84903E-9797-4221-A5BB-487C08BB2AC5Q36697501-BCE12FAF-0166-4515-8F9C-F196E8B99C28Q37108498-B15A420E-67C8-4C92-A06D-92301E30AAD2Q37376539-E09BF7F4-6A4C-4B8A-AAD1-77CC75E59042Q37580235-68F89A09-EF5C-4A97-8CE6-DC028ABA5405Q37973378-38A6744E-A660-420E-8BDF-5B519F56112AQ38371584-331EC4B9-F74B-4090-9759-E0FC58B0512BQ39025959-A34E5380-A7DF-4B78-8D95-A1EB21BFE9C3Q41943120-9F3D2DC1-15D0-4C8F-B582-838E4681D0A9Q44340496-2D4DF17B-518A-4E87-B43D-C375B9D7A0B9Q45266202-315EA641-7AA2-49D2-A6CA-A8CA45C82D32Q46935266-2B67968A-B62A-4420-BA71-ACF9843C3DCDQ48472286-BE3A99CA-0FDE-4C41-85C5-93C8C5C32277Q50959625-80F44450-2627-4B3D-B6D2-3333CBE0E533
P2860
The therapeutic potential of neuronal KCNQ channel modulators.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The therapeutic potential of neuronal KCNQ channel modulators.
@ast
The therapeutic potential of neuronal KCNQ channel modulators.
@en
type
label
The therapeutic potential of neuronal KCNQ channel modulators.
@ast
The therapeutic potential of neuronal KCNQ channel modulators.
@en
prefLabel
The therapeutic potential of neuronal KCNQ channel modulators.
@ast
The therapeutic potential of neuronal KCNQ channel modulators.
@en
P2860
P356
P1476
The therapeutic potential of neuronal KCNQ channel modulators.
@en
P2093
Valentin K Gribkoff
P2860
P304
P356
10.1517/14728222.7.6.737
P407
P577
2003-12-01T00:00:00Z